CoChat

Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia

Open access
Togasaki, E, Takeda, J, Yoshida, K, Shiozawa, Y, Takeuchi, M, Oshima, M, Saraya, A, Iwama, A, Yokote, K, Sakaida, E, Hirase, C, Takeshita, A, Imai, K, Okumura, H, Morishita, Y, Usui, N, Takahashi, N, Fujisawa, S, Shiraishi, Y, Chiba, K, Tanaka, H, Kiyoi, H, Ohnishi, K, Ohtake, S, Asou, N, Kobayashi, Y, Miyazaki, Y, Miyano, S, Ogawa, S, Matsumura, I, Nakaseko, C, Naoe, T, for the Japan Adult Leukemia Study Group (JALSG) · 2017 · Blood Cancer Journal
Cited by 61

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Although tyrosine kinase inhibitors (TKIs) have significantly improved the prognosis of chronic myeloid leukemia (CML), the ability of TKIs to eradicate CML remains uncertain and patients must continue TKI therapy for indefinite periods. In this study, we performed whole-exome sequencing to identify somatic mutations in 24 patients with newly diagnosed chronic phase CML who were registered in the JALSG CML212 study. We identified 191 somatic mutations other than the BCR-ABL1 fusion gene (median 8, range 1–17). Age, hemoglobin concentration and white blood cell counts were correlated with the number of mutations. Patients with mutations ⩾6 showed higher rate of achieving major molecular response than those<6 (P=0.0381). Mutations in epigenetic regulator, ASXL1, TET2, TET3, KDM1A and MSH6 were found in 25% of patients. TET2 or TET3, AKT1 and RUNX1 were mutated in one patient each. ASXL1 was mutated within exon 12 in three cases. Mutated genes were significantly enriched with cell signaling and cell division pathways. Furthermore, DNA copy number analysis showed that 2 of 24 patients had uniparental disomy of chromosome 1p or 3q, which disappeared major molecular response was achieved. These mutations may play significant roles in CML pathogenesis in addition to the strong driver mutation BCR-ABL1.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/bcj.2017.36

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

Metadata

Authors
Togasaki, E., Takeda, J., Yoshida, K., Shiozawa, Y., Takeuchi, M., Oshima, M., Saraya, A., Iwama, A., Yokote, K., Sakaida, E., Hirase, C., Takeshita, A., Imai, K., Okumura, H., Morishita, Y., Usui, N., Takahashi, N., Fujisawa, S., Shiraishi, Y., Chiba, K., Tanaka, H., Kiyoi, H., Ohnishi, K., Ohtake, S., Asou, N., Kobayashi, Y., Miyazaki, Y., Miyano, S., Ogawa, S., Matsumura, I., Nakaseko, C., Naoe, T., & for the Japan Adult Leukemia Study Group (JALSG)
Venue
Blood Cancer Journal
Published
2017-04-28
Volume
7
Issue
4
Pages
e559-e559
ISSN
2044-5385 (ISSN-L)
OpenAlex
W2608720200
Cited by
61
References
9
FWCI
4.52
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.